DCF — SOUTHERN NH MEDICAL CENTER
Enterprise Value: $-85.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-85.4M
Enterprise Value
$-35.4M
PV of Cash Flows
$-50.0M
PV of Terminal Value
$-80.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $301.8M | $-0.8M | -0.0% | $-13.5M | $-12.3M |
| Year 2 | $310.8M | $2.3M | 1.0% | $-10.8M | $-9.0M |
| Year 3 | $320.2M | $5.6M | 2.0% | $-8.0M | $-6.0M |
| Year 4 | $329.8M | $7.4M | 2.0% | $-6.5M | $-4.5M |
| Year 5 | $339.7M | $8.5M | 2.0% | $-5.9M | $-3.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-85.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$293.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.007523397693103894
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5